Legal Representation
Attorney
Katie Miller
USPTO Deadlines
Next Deadline
2163 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-08)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 16, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 10, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 10, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 10, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 10, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 20, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 20, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 20, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 15, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 14, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 26, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Reagents, cells, cell culture media for scientific or non-clinical research use only
First Use Anywhere:
Dec 30, 2014
First Use in Commerce:
Dec 30, 2014
Class 042
Scientific and medical research services, namely, providing CRO laboratory services that support drug discovery and development, namely, disease relevant cell models, stem cell development, cellular engineering services, primary cell isolation, drug screening, and various in-vitro assays; pre-clinical medical research
First Use Anywhere:
Dec 30, 2014
First Use in Commerce:
Dec 30, 2014
Additional Information
Pseudo Mark
IX CELLS BIOTECHNOLOGIES; NINE CELLS BIOTECHNOLOGIES; 9 CELLS BIOTECHNOLOGIES; NINECELLS BIOTECHNOLOGIES; 9CELLS BIOTECHNOLOGIES
Classification
International Classes
001
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECHNOLOGIES"